Gelesis Holdings Price to Book Ratio 2021-2022 | GLS
Historical price to book ratio values for Gelesis Holdings (GLS) over the last 10 years. The current price to book ratio for Gelesis Holdings as of February 03, 2023 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Gelesis Holdings Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2023-02-03 |
0.33 |
|
0.00 |
| 2022-09-30 |
1.08 |
$-0.05 |
-21.91 |
| 2022-06-30 |
1.55 |
$0.07 |
22.05 |
| 2022-03-31 |
4.53 |
$0.14 |
32.66 |
| 2021-12-31 |
9.96 |
$-2.62 |
-3.80 |
| 2021-09-30 |
9.92 |
$-6.42 |
-1.54 |
| 2021-06-30 |
9.79 |
$0.48 |
20.40 |
| 2021-03-31 |
9.76 |
$0.50 |
19.53 |
| 2020-12-31 |
10.15 |
|
0.00 |
| 2020-09-30 |
9.83 |
$0.61 |
16.21 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.024B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
